On August 12, 2026, the Chinese robotics industry is experiencing a genuine boom. Next week in Shanghai, trading is set to begin for the shares of Unitree Robotics, one of the world leaders in humanoid robot production. Market expectations have reached a peak: the initial public offering (IPO) was oversubscribed 8,000 times. According to Reuters, the company's valuation stands at an impressive $8.9 billion.
Financial Hype and IPO Parameters
The IPO parameters look impressive. The offering price per share is set at $22.36. However, as analysts note, the chances for retail investors to get a "slice of the pie" from this IPO are minimal. Due to the colossal imbalance between supply and demand, institutional investors will receive priority, while retail buyers will receive only a limited number of lots. Nevertheless, experts predict that after the stock market debut, Unitree's share price will grow manifold, making participation in the IPO extremely profitable for those lucky enough to get in.
China's Dominance in the Global Market
Unitree's success is not just the story of one company, but an indicator of a general trend. By 2026, Chinese suppliers have seized a dominant position, controlling 97% of the global humanoid robot market. Unitree, whose models (such as the G1 robot shown in the photo) have already become a recognizable brand, is one of the key players in this market. The hype surrounding the IPO illustrates investors' readiness to invest in a sector that is demonstrating rapid growth and transitioning from demonstration models to real commercial use.
Contradictory Data
Despite the generally positive atmosphere, there are discrepancies and risks in the analytical reports. First, there are discrepancies in the exact figures of oversubscription: Reuters reports a coefficient of 8,000 times, while The Asset publication cites a figure of 8,200 times. Second, experts warn of possible risks. On the one hand, Unitree's IPO could trigger a wave of asset revaluation for other robot manufacturers (such as Ouster, Symbotic, and Teradyne), leading to an increase in their stock prices. On the other hand, there is a risk of market correction due to geopolitics. The US is considering a bill to ban the import of robots of Chinese origin, which could negatively affect the long-term prospects and stock prices of Chinese issuers, including Unitree.
Impact on the Global Market
Unitree's listing will become a catalyst for the entire robotics sector. Investors will closely monitor the dynamics of the shares to adjust their portfolios. If Unitree's shares show explosive growth, it could trigger a boom in the stocks of other companies engaged in AI and automation. However, if US geopolitical restrictions come into force, this will create a "glass ceiling" for the growth of Chinese tech giants, forcing them to reorient towards the domestic market and countries not participating in sanction regimes.
